or Try an Advanced Search...

    Technical Analysis for CRBP - Corbus Pharmaceuticals Holdings, Inc.

    Grade Last Price % Change Price Change
    F 17.82 1.02% 0.18
    CRBP closed up 1.02 percent on Friday, November 29, 2024, on 12 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical CRBP trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    BB Squeeze Started Range Contraction 0.00%
    20 DMA Support Bullish 1.02%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.89%
    Spinning Top Other -0.89%
    NR7 Range Contraction -0.89%
    Narrow Range Bar Range Contraction -0.89%
    Inside Day Range Contraction -0.89%
    Older End-of-Day Signals for CRBP ...

       Recent Intraday Alerts

    Alert Time
    Up 2% 2 days ago
    60 Minute Opening Range Breakout 2 days ago
    Fell Below Previous Day's Low 2 days ago
    20 DMA Resistance 2 days ago
    Fell Below 20 DMA 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CRBP Chart by TradingView
    Basic chart:

    Profile

    Corbus Pharmaceuticals Holdings, Inc., a clinical stage biopharmaceutical company, develops and commercializes novel therapeutics to treat inflammatory-fibrotic diseases. The company primarily develops Resunab, an oral anti-inflammatory drug that has completed Phase I clinical trials for the treatment of cystic fibrosis and diffuse scleroderma. It sells its products through hearing professionals, including audiologists, hearing aid specialists, and ENT doctors worldwide. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Organ Systems Hearing Cystic Fibrosis Hearing Aid Fibrotic Disease Treatment Of Cystic Fibrosis Ajulemic Acid Channelopathies Scleroderma

    Is CRBP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 26 Corbus Pharmaceuticals Holdings, Inc. (CRBP): An Oversold Healthcare Stock to Invest In Now
    Nov 21 Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference
    Nov 12 Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
    Nov 11 Corbus Pharmaceuticals' Sell-Off: Speculative Entry Price In Oncology And Obesity Therapies
    Nov 9 We're Not Very Worried About Corbus Pharmaceuticals Holdings' (NASDAQ:CRBP) Cash Burn Rate
    Nov 7 Corbus Pharmaceuticals: Q3 Earnings Snapshot
    Nov 7 Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update
    Nov 4 Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat
    Nov 4 Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024
    Oct 29 Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference
    See more CRBP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 61.9
    52 Week Low 4.99
    Average Volume 765,595
    200-Day Moving Average 38.73
    50-Day Moving Average 18.24
    20-Day Moving Average 17.72
    10-Day Moving Average 17.16
    Average True Range 1.15
    RSI (14) 45.05
    ADX 19.96
    +DI 21.09
    -DI 23.21
    Chandelier Exit (Long, 3 ATRs) 17.32
    Chandelier Exit (Short, 3 ATRs) 19.10
    Upper Bollinger Bands 19.43
    Lower Bollinger Band 16.01
    Percent B (%b) 0.53
    BandWidth 19.30
    MACD Line -0.87
    MACD Signal Line -1.30
    MACD Histogram 0.4346
    Fundamentals Value
    Market Cap 184.2 Million
    Num Shares 10.3 Million
    EPS -11.12
    Price-to-Earnings (P/E) Ratio -1.60
    Price-to-Sales 163.32
    Price-to-Book 744.81
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 18.63
    Resistance 3 (R3) 18.60 18.31 18.50
    Resistance 2 (R2) 18.31 18.10 18.32 18.45
    Resistance 1 (R1) 18.06 17.97 18.19 18.09 18.40
    Pivot Point 17.77 17.77 17.83 17.78 17.77
    Support 1 (S1) 17.52 17.56 17.65 17.55 17.24
    Support 2 (S2) 17.23 17.43 17.24 17.19
    Support 3 (S3) 16.98 17.23 17.15
    Support 4 (S4) 17.01